This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/TRVI/capital-change-brief"
Use Arkolith's capital_change_brief for TRVI. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | NEA Management Company, LLC | $157.7M | 13.2M | —Held | Q1 2026 | |
| 2 | BlackRock, Inc. | $122.2M | 10.2M | ▲+1.1% Added · +114K sh | Q1 2026 | |
| 3 | Frazier Life Sciences Management, L.P. | $118.6M | 9.9M | ▼−3.1% Reduced · −320K sh | Q1 2026 | |
| 4 | FMR LLC | $95.9M | 8.0M | ▲+24% Added · +1.5M sh | Q1 2026 | |
| 5 | Vivo Capital, LLC | $60.8M | 5.1M | —Held | Q1 2026 | |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $59.4M | 5.0M | ▲New +5.0M sh | Q1 2026 | |
| 7 | MARSHALL WACE, LLP | $47.3M | 4.0M | ▼−13% Reduced · −615K sh | Q1 2026 | |
| 8 | Rubric Capital Management LP | $44.3M | 3.7M | ▼−1.4% Reduced · −54K sh | Q1 2026 | |
| 9 | MPM BioImpact LLC | $39.4M | 3.3M | ▲+0.3% Added · +11K sh | Q1 2026 | |
| 10 | VIKING GLOBAL INVESTORS LP | $38.2M | 3.2M | —Held | Q1 2026 | |
| 11 | ALLIANCEBERNSTEIN L.P. | $35.6M | 2.8M | ▼−7.7% Reduced · −238K sh | Q1 2026 | |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | $33.2M | 2.8M | ▲+15% Added · +365K sh | Q1 2026 | |
| 13 | STATE STREET CORP | $31.8M | 2.7M | ▲+9.4% Added · +230K sh | Q1 2026 | |
| 14 | EVENTIDE ASSET MANAGEMENT, LLC | $31.3M | 2.6M | —Held | Q1 2026 | |
| 15 | ORBIMED ADVISORS LLC | $29.3M | 2.5M | ▼−23% Reduced · −736K sh | Q1 2026 | |
| 16 | Logos Global Management LP | $28.6M | 2.4M | ▲+55% Added · +850K sh | Q1 2026 | |
| 17 | Vestal Point Capital, LP | $25.8M | 2.2M | ▲New +2.2M sh | Q1 2026 | |
| 18 | ACORN CAPITAL ADVISORS, LLC | $25.6M | 2.1M | —Held | Q1 2026 | |
| 19 | Artia Global Partners LP | $24.0M | 2.0M | —Held | Q1 2026 | |
| 20 | Affinity Asset Advisors, LLC | $23.9M | 2.0M | ▼−7.0% Reduced · −150K sh | Q1 2026 | |
| 21 | FRONTIER CAPITAL MANAGEMENT CO LLC | $23.8M | 2.0M | ▲+80% Added · +886K sh | Q1 2026 | |
| 22 | EMERALD ADVISERS, LLC | $21.9M | 1.8M | ▼−2.8% Reduced · −53K sh | Q1 2026 | |
| 23 | Siren, L.L.C. | $21.3M | 1.8M | ▼−22% Reduced · −500K sh | Q1 2026 | |
| 24 | Pictet Asset Management Holding SA | $20.4M | 1.7M | ▲+11% Added · +174K sh | Q1 2026 | |
| 25 | RAYMOND JAMES FINANCIAL INC | $20.1M | 1.7M | ▼−4.5% Reduced · −79K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 3, 2026 | Colangelo Dominick | Director | Grant (A) | 35K | $0 |
| Jun 3, 2026 | Meeker David P | Director | Grant (A) | 35K | $0 |
| Jun 3, 2026 | Mathers Edward T | Director | Grant (A) | 35K | $0 |
| Jun 3, 2026 | Heffernan Michael Thomas | Director | Grant (A) | 35K | $0 |
| Jun 3, 2026 | VANLENT ANNE | Director | Grant (A) | 35K | $0 |
| Feb 19, 2026 | Simon Farrell | Chief Commercial Officer | Grant (A) | 160K | $0 |
| Feb 19, 2026 | GOOD JENNIFER L | President & CEO, Director | Grant (A) | 675K | $0 |
| Feb 19, 2026 | SCIASCIA THOMAS | Chief Scientific Officer | Grant (A) | 85K | $0 |
| Feb 19, 2026 | Galletta Christopher | See Remarks | Grant (A) | 35K | $0 |
| Feb 19, 2026 | Cassella James V | Chief Development Officer | Grant (A) | 215K | $0 |
| Jan 8, 2026 | HASTINGS DAVID C | Chief Financial Officer | Grant (A) | 375K | $0 |
| Dec 2, 2025 | Galletta Christopher | See Remarks | Option exercise (M) | 4K | $2K |
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 52 funds | $6.9B |
| BOSTON SCIENTIFIC CORPBSX | 52 funds | $2.4B |
| UNITED THERAPEUTICS CORPUTHR | 52 funds | $986.6M |
| AMAZON.COM INCAMZN | 51 funds | $19.8B |
| ALPHABET INC-CL AGOOGL | 51 funds | $18.1B |
| MICROSOFT CORPMSFT | 50 funds | $26.3B |
| BROADCOM INCAVGO | 50 funds | $15.3B |
| META PLATFORMS INC-CLASS AMETA | 50 funds | $12.7B |
| GILEAD SCIENCES INCGILD | 50 funds | $2.8B |
| INTUITIVE SURGICAL INCISRG | 50 funds | $2.6B |
| NVIDIA CORPNVDA | 49 funds | $41.1B |
| TESLA INCTSLA | 49 funds | $9.6B |
Ranked by how many of TRVI's institutional holders also hold each name, a cross-fund conviction signal. Via the MCP server (ticker.co_held).
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for TRVI. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.